Previous Close | 21.30 |
Open | 21.30 |
Bid | 19.90 |
Ask | 23.60 |
Strike | 60.00 |
Expire Date | 2024-12-20 |
Day's Range | 21.30 - 21.30 |
Contract Range | N/A |
Volume | |
Open Interest | 6 |
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive acquisitions.
Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.